Putative drug-related pemphigus foliaceus in four dogs

Veterinary Dermatology

Volumn 13, Issue 4, 2002, Pages 195-202

  White, Stephen D ^a   Carlotti, Didier N ^b   Pin, Didier ^b   Bonenberger, Terri ^a   Ihrke, Peter J ^a   Monet, Eric ^c   Nishifuji, Koji ^d   Iwasaki, Toshiroh ^d   Papich, Mark G ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cabinet de Dermatol Veterinaire   (France)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Adverse drug reaction; Antibiotics; Dogs; Pemphigus foliaceus; Skin lesions

Indexed keywords

CANIS FAMILIARIS; PEMPHIGUS;

ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; DRUG ERUPTION; FEMALE; MALE; PATHOLOGY; PEMPHIGUS;

ANIMALS; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; DRUG ERUPTIONS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGUS;

EID: 0036674410     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3164.2002.00297.x     Document Type: Article

References (41)

1. Ihrke, P.J., Stannard, A.A., Ardans, A.A., Griffin, C.E. Pemphigus foliaceus in dogs: a review of 37 cases. Journal of the American Veterinary Medical Association 1985; 186: 59-66.
2. Wurm, S., Mattise, A.W., Dunstan, R.W. Comparative pathology of pemphigus in dogs and humans. Clinics in Dermatology 1994; 12: 515-24.
3. Suter, M.M., de Bruin, A., Wyder, M. et al. Autoimmune diseases of domestic animals: an update. In: Kwochka, K.W., Willemse, T., Von Tscharner, C., eds. Advances in Veterinary Dermatology, Vol. 3. Oxford: Butterworth Heinemann 1998, 321-37.
4. Iwasaki, T., Shimizu, M., Obata, H. et al. Detection of canine pemphigus foliaceus autoantigen by immunoblotting. Veterinary Immunology and Immunopathology 1997; 59: 1-10.
5. Wolf, R., Tamir, A., Brenner, S. Drug-induced versus drug-triggered pemphigus. Dermatologica 1991; 182: 207-10.
6. Medleau, L., Shanley, K.J., Rakich, P.M., Goldschmidt, M.H. Trimethoprim-sulfonamide-associated drug eruptions in dogs. Journal of the American Animal Hospital Asssociation 1990; 26: 305-11.
7. Noli, C., Koeman, J.P., Willemse, T. A retrospective evaluation of adverse reactions to trimethoprimsulphonamide combinations in dogs and cats. Veterinary Quarterly 1995; 17: 123-8.
8. Brenner, S., Wolf, R., Ruocco, V. Drug-induced pemphigus. I. A survey. Clinics in Dermatology 1993; 11: 501-5.
9. Marsella, R., Nicklin, C.F., Munson, J.W., Roberts, S.M. Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration. American Journal of Veterinary Research 2000; 61: 631-7.
10. Olivry, T., Dunston, S.M., Schachter, M. et al. A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. Journal of Autoimmunity 2001; 16: 411-21.
11. Brenner, S., Bialy-Golan, A., Ruocco, V. Drug-induced pemphigus. Clinics in Dermatology 1998; 16: 393-7.
12. Wilson, J.P., Koren, J.F., Daniel, R.C., 3rd, Chapman, S.W. Cefadroxil-induced ampicillin-exacerbated pemphigus vulgaris: case report and review of the literature. Drug Intelligence and Clinical Pharmacology 1986; 20: 219-23.
13. de Angelis, E., Lombardi, M.L., Grassi, M., Ruocco, V. Enalapril: a powerful in vitro non-thiol acantholytic agent. International Journal of Dermatology 1992; 31: 722-4.
14. Wolf, R., Ruocco, V. Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Medical Hypotheses 1997; 48: 107-10.
15. Korman, N.J., Eyre, R.W., Zone, J., Stanley, J.R. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. Journal of Investigative Dermatology 1991; 96: 273-6.
16. Brenner, S., Bialy-Golan, A., Anhalt, G.J. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. Journal of the American Academy of Dermatology 1997; 36: 919-23.
17. Kuechle, M.K., Hutton, K.P., Muller, S.A. Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review. Mayo Clinic Proceedings 1994; 69: 1166-71.
18. Ruocco, V., De Angelis, E., Lombardi, M.L. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clinics in Dermatology 1993; 11: 507-13.
19. Lombardi, M.L., de Angelis, E., Rossano, F., Ruocco, V. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis. Dermatology 1993; 186: 118-22.
20. Wolf, R., Brenner, S. An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? Dermatology 1994; 189: 1-4.
21. McEwan, N.A., McNeil, P.E., Kirkham, D., Sullivan, M. Drug eruption in a cat resembling pemphigus foliaceus. Journal of Small Animal Practice 1987; 28: 713-20.
22. Mason, K.V., Day, M.J. A pemphigus foliaceus-like eruption associated with the use of ampicillin in a cat. Australian Veterinary Journal 1987; 64: 223-4.
23. Prélaud, P., Mialot, M., Kupfer, B. Accident cutané médicamenteux évoquant un pemphigus foliacé chez un chat. Point Vétérinaire 1991; 23: 313-8.
24. Hinn, A.C., Olivry, T., Luther, P.B., Cannon, A.G., Yaeger, Y.A. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in the dog: clinical classification, drug exposure, and histopathological correlations. Veterinary Allergy and Clinical Immunology 1998; 6: 13-20.
25. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Goodman, A.G., eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill 1996, 904-1185.
26. Trepanier, L.A., Ray, K., Winand, N., Spielberg. S.P., Cribb, A.E. Cytosolic arlyamine N-acetyltransferase deficiency in the dog and other canids due to an absence of NAT genes. Biochemical Pharmacology 1997; 54: 73-80.
27. Trepanier, L.A. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. Veterinary Dermatology 1999; 10: 241-8.
28. Cribb, A.E., Pohl, L., Spielber, S.P., Leeder, J.S. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. Journal of Pharmacology and Experimental Therapeutics 1997; 282: 1064-72.
29. Kuhl, K.A., Shofer, F.S., Goldschmidt, M.H. Comparative histopathology of pemphigus foliaceus and superficial folliculitis in the dog. Veterinary Pathology 1994; 31: 19-27.
30. Parker, W.M., Yager, J.A. Trichophyton dermatophytosis - a disease easily confused with pemphigus erythematosus. Canadian Veterinary Journal 1997; 38: 502-5.
31. Poisson, L., Mueller, R.S., Olivry, T. Dermatophytose pustuleuse cornéophilique canine évoquant un pemphigus foliacé. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 1998; 33: 229-34.
32. Affolter, V.K., von Tscharner, C. Cutaneous drug reactions: a retrospective study of histopathological changes with their correlation to the clinical disease. Veterinary Dermatology 1993; 4: 79-86.
33. Landau, M., Brenner, S. Histopathologic findings in drug-induced pemphigus. American Journal of Dermatopathology 1997; 19: 411-4.
34. Scott, D.W., Smith, F.W.K., Smith, C.A. Erythema multiforme and pemphigus-like antibodies associated with sulfamethoxazole-trimethoprim administration in a dog with polycystic kidneys. Canine Practice 1986; 13: 35-8.
35. Kalish, R.S. Pemphigus vulgaris: the other half of the story. Journal of Clinical Investigation 2000; 106: 1433-5.
36. Harman, K.E., Seed, P.T., Gratian, M.J., Bhogal, B.S., Challacombe, S.J., Black, M.M. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. British Journal of Dermatology 2001; 144: 775-80.
37. Amagai, M., Matsuyoshi, N., Wang, Z.H., Andl, C., Stanley, J.R. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nature Medicine 2000; 6: 1275-7.
38. Gross, T.L., Ihrke, P.J., Walder, E.J. Veterinary Dermatology: a Macroscopic and Microscopic Evaluation of Canine and Feline Skin Disease. St. Louis, MO: Mosby-Yearbook 1992, 10-2.
39. Love, D.N., Davis, P.E. Isolation of Staphylococcus aureus from a condition in Greyhounds histologically resembling 'staphylococcal scalded skin syndrome' of man. Journal of Small Animal Practice 1980; 21: 351-7.
40. Barrs, V.R., Briscoe, D., Malik, R., Love, D.N. Use of multilocus enzyme electrophoresis to distinguish clinically important strains of Staphylococcus intermedius from the skin of dogs. Australian Veterinary Journal 2000; 78: 267-72.
41. Kishimoto, K., Iwatsuki, K., Akiba, H., Motoki, Y., Kaneko, F. Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs. European Journal of Dermatology 2001; 11: 41-4.